Refugees, migrants and health

On 20 June 2017 – the United Nations World Refugee Day – Abbas et al (2018) convened a workshop during the 4th International Conference on Prevention and Infection Control in Geneva. The authors note...

Living with long COVID

The new guideline for NICE (2021) recommends that patients presenting with new or ongoing symptoms 4 weeks or later after an initial COVID-19 infection should have the following investigations done; a...

Remote consultations, prescribing and virtual teaching during the COVID-19 pandemic

Before the pandemic, the modernisation of the NHS included digitalisation and the use of remote consultations (NHS UK, 2019; Welsh Government, 2019; NHS Digital, 2020). There had been a slow but...

The role of community pharmacies during the COVID-19 pandemic

Pharmacies have played a vital role during the pandemic, not only by ensuring a stable supply of key medicines, but also in becoming an information hub regarding the virus. Many pharmacies are now the...

Prescribing issues in the COVID-19 pandemic

As we know as prescribers, antibiotic stewardship and appropriate prescribing of antibiotic therapy to reduce this incidence of resistance is an often-focussed field of research (Zhu et al, 2021). In...

Managing diabetes care in the COVID-19 pandemic

This piece of original research, carried out in May 2020 in China, used a questionnaire method to gather information about diabetic patients as a measure to determine recruitment before conducting a...

COVID-19 research and non-vaccine treatment

How world policy affects the equitable distribution of the COVID-19 vaccine

In a study recently published in the British Medical Journal, So and Woo (2020) analysed the premarket purchase commitments for COVID-19 vaccines from leading manufacturers to recipient countries.

Remote healthcare in the COVID-19 pandemic

This editorial published online in the Journal of Psychotherapy and Psychosomatics near the beginning of the pandemic looked at issues and aspects to consider when conducting what they term...

Care continues to shine in difficult times

This has been a truly exceptional year for the world, the UK, the NHS and us as healthcare professionals. For me 2020 has been a true year of ups and downs and I mean this personally and...

Treating and preventing COVID-19: how close are we?

The antibody drug, Regeneron, was partially credited for successfully treating outgoing American President Donald Trump. It has now received emergency approval in the US for use in people who have...

COVID-19, coagulopathy and clotting abnormalities

This review article from Tokyo in Japan was published in March 2020 and outlined what was being seen by clinicians dealing with ill patients in the first wave of the COVID-19 pandemic (Iba et al,...